baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AbbVie Inc/ US00287Y1091 /

5/21/2025 9:59:59 PM	Chg. -3.16	Volume	Bid5/21/2025	Ask5/21/2025	Market Capitalization	Dividend Y.	P/E Ratio
181.74USD	-1.71%	145,798 Turnover: 26.63 mill.	181.75Bid Size: 100	190.00Ask Size: 100	321.13 bill.USD	3.46%	75.75

Newsfile Corp 6:37 AM ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counse...

GlobeNewswire 3:00 AM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Can...

GlobeNewswire 5/21 Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm ...

Newsfile Corp 5/21 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secu...

GlobeNewswire 5/20 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure C...

GlobeNewswire 5/19 Cerevel Therapeutics Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your l...

GlobeNewswire 5/19 Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics...

Newsfile Corp 5/18 CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

Newsfile Corp 5/18 ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counse...

Newsfile Corp 5/17 ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counse...

GlobeNewswire 5/16 Royalty Pharma Completes the Acquisition of Its External Manager

GlobeNewswire 5/16 CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

Newsfile Corp 5/16 ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure ...

GlobeNewswire 5/16 Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therap...

GlobeNewswire 5/16 Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: ...

GlobeNewswire 5/15 The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit ...

GlobeNewswire 5/15 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Can...

Newsfile Corp 5/14 ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure...

GlobeNewswire 5/14 Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update

Newsfile Corp 5/13 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure C...

GlobeNewswire 5/13 Levi & Korsinsky Notifies Shareholders of Cerevel Therapeutics Holdings, Inc.(ABBV) of a Class Actio...

GlobeNewswire 5/13 Royalty Pharma to Present at Upcoming Investor Conferences

GlobeNewswire 5/12 Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

Newsfile Corp 5/12 ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counse...

Newsfile Corp 5/12 CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

AbbVie Inc/ US00287Y1091 /

If you wish to receive reply to your feedback, please provide your email address.